<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230111057106N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-02-23</date_registration>
      <primary_sponsor>Guilan University Of Medical Sciences</primary_sponsor>
      <public_title>The comparison analgesic effect of fentanyl plus midazolam or fentanyl plus propofol on patients during cataract surgery under peribulbar block</public_title>
      <acronym></acronym>
      <scientific_title>The comparison analgesic effect of fentanyl plus midazolam or fentanyl plus propofol on patients during cataract surgery under peribulbar block: A randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>116</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68014</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method of this study is based on four random blocks. According to the sample size, 27 random blocks are done through the Random Allocation software, and the patients are divided into two groups A (fentanyl-midazolam) and B (fentanyl - Propofol) based on the list of the sequence of random blocks according to the daily visits and having the inclusion criteria, are randomly assigned, Blinding description: The type of anesthesia is not explained to the patient.</study_design>
      <phase>3</phase>
      <hc_freetext>catarct.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group receives a sedation with fentanyl 0.5g/kg and it is repeated for 5-10 minutes. After that, midazolam 0.01mg/kg - Hyalase patients also receive. Intervention 2: Intervention group: The intervention group received two sedation with fentanyl 0.5g/kg and repeated for 5-10 minutes - patients also received hyalase.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Hassan behboudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Eye Research Center, Amiralmomenin Hospital, 17 Shahrivar St, Rasht</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>41396-37459</zip>
        <telephone>+98 13 3323 6886</telephone>
        <email>behboudi_dr@yahoo.com</email>
        <affiliation>Guilan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Hassan Behboudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Eye Research Center, Amiralmomenin Hospital, 17 Shahrivar St, Rasht</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>41396-37459</zip>
        <telephone>+98 31 3323 6886</telephone>
        <email>behboudi_dr@yahoo.com</email>
        <affiliation>Guilan University Of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Unilateral cataract surgery
patients aged 50-80 years with ASA class I, II
elective surgery
fasting patients
surgeries performed under peribulbar block by an ophthalmologist with more than 25 years of experience</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>ASA &gt; 3
surgeries performed under other blocks or general anesthesia
coagulation disorder
use of antiplatelet drugs
head tremor (Parkinson's)
cognitive disorder
Alzheimer's
fear of closed spaces
history of chronic cough
addiction and history of use Analgesic drugs
allergies to local anesthetic drugs
non-cooperative patients</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H25.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Age-related cataract, morgagnian type</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group receives a sedation with fentanyl 0.5g/kg and it is repeated for 5-10 minutes. After that, midazolam 0.01mg/kg - Hyalase patients also receive.</i_keyword>
      <i_keyword>Intervention group: The intervention group received two sedation with fentanyl 0.5g/kg and repeated for 5-10 minutes - patients also received hyalase.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Degree of sedation using corrected Ramsay scale( RSS&gt;3). Timepoint: Every 5 minutes. Method of measurement: Clinical examination.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Patient satisfaction level. Timepoint: Evaluation of patients' satisfaction using a five-point Likert scale, according to statistics, 33.3 is poor, 33.3-66.6 is average, and 66.6 or higher is good.between the end of surgery and transfer to the ward (recovery time). Method of measurement: In the study "The comparison analgesic effect of fentanyl plus midazolam or fentanyl plus propofol on patients during cataract surgery under peribulbar block", the way to set up the secondary variable of patient satisfaction can be a "five-point Likert scale". according to statistics, 33.3 is poor, 33.3-66.6 is average, and 66.6 or higher is good.</sec_outcome>
      <sec_outcome>Surgeon satisfaction level. Timepoint: Evaluation of surgen's satisfaction using a five-point Likert scale, according to statistics, 33.3 is poor, 33.3-66.6 is average, and 66.6 or higher is good.between the end of surgery and transfer to the ward (recovery time). Method of measurement: In the study "The comparison analgesic effect of fentanyl plus midazolam or fentanyl plus propofol on patients during cataract surgery under peribulbar block", the method of setting up the secondary variable of surgeon satisfaction can be a five-point Likert scale. according to statistics, 33.3 is poor, 33.3-66.6 is average, and 66.6 or higher is good.</sec_outcome>
      <sec_outcome>Anesthesia complications. Timepoint: Anesthesia complications is evaluated using a five-point Likert scale, according to statistics, 33.3 is poor, 33.3-66.6 is average, and 66.6 or higher is good. The time between the end of surgery and transfer to the ward (recovery time) is recorded. Method of measurement: In the study "The comparison analgesic effect of fentanyl plus midazolam or fentanyl plus propofol on patients during cataract surgery under peribulbar block", the secondary variable of anesthesia complications can be set up using a five-point Likert scale. according to statistics, 33.3 is poor, 33.3-66.6 is average, and 66.6 or higher is good.</sec_outcome>
      <sec_outcome>Recovery time. Timepoint: Recovery time is evaluated using a five-point Likert scale, according to statistics, 33.3 is poor, 33.3-66.6 is average, and 66.6 or higher is good. The time between the end of surgery and transfer to the ward (recovery time) is recorded. Method of measurement: In the study "The comparison analgesic effect of fentanyl plus midazolam or fentanyl plus propofol on patients during cataract surgery under peribulbar block" the secondary variable of recovery time can be "five-point Likert scale". according to statistics, 33.3 is poor, 33.3-66.6 is average, and 66.6 or higher is good.</sec_outcome>
      <sec_outcome>Pain intensity. Timepoint: every 5 minutes. Method of measurement: clinical examination.</sec_outcome>
      <sec_outcome>Heart rate. Timepoint: every 5 minutes. Method of measurement: clinical examination.</sec_outcome>
      <sec_outcome>SpO2 percentage of arterial saturation. Timepoint: every 5 minutes. Method of measurement: clinical examination.</sec_outcome>
      <sec_outcome>Intraoperative pain. Timepoint: every 5 minutes. Method of measurement: clinical examination.</sec_outcome>
      <sec_outcome>Blood pressure. Timepoint: every 5 minutes. Method of measurement: clinical examination.</sec_outcome>
      <sec_outcome>Arterial blood pressure. Timepoint: every 5 minutes. Method of measurement: clinical examination.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Guilan University Of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-07</approval_date>
        <contact_name>Ethics committee of Guilan University of Medical Sciences</contact_name>
        <contact_address>Shahid Siadaty St., Namju St., Rasht Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
